Schedule 13G ownership disclosure
ALPINE IMMUNE SCIENCES INC
Security class unavailable · CUSIP: 02083G100
Event date: 2022-04-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,537,345
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-22-002655
- Form type
- SC 13G
- Filer
- ALPINE IMMUNE SCIENCES, INC.
- CIK
- CIK 1626199
- Filed
- Apr 22, 2022
- Reporting period
- Apr 14, 2022
- Description
- Schedule 13G beneficial ownership